We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





EpiGentek Launches First-to-Market Kits to Detect SARS-CoV-2-Targeted Furin Activity and Screen for Inhibitors Against COVID-19

By LabMedica International staff writers
Posted on 10 Jul 2020
Print article
Image: EpiGentek Launches First-to-Market Kits to Detect SARS-CoV-2-Targeted Furin Activity and Screen for Inhibitors against COVID-19 (Photo courtesy of EpiGentek)
Image: EpiGentek Launches First-to-Market Kits to Detect SARS-CoV-2-Targeted Furin Activity and Screen for Inhibitors against COVID-19 (Photo courtesy of EpiGentek)
EpiGentek (Farmingdale, NY, USA) has released a series of SARS-CoV-2 research assays that focuses on studies of SARS-CoV-2 targeted furin or proprotein convertase (PC) cleavage activity.

These first-of-its-kind tools can be used to rapidly detect SARS-CoV-2 targeted PC and facilitated proteases using biological samples as well as screen for inhibitors of these enzymes that cleave SARS-CoV-2 proteins. Subsequent implications can be the effective development of drug candidates or therapeutic treatments.

The SARS-CoV-2 spike glycoprotein harbors a furin/PC cleavage site at the boundary between the S1/S2 subunits, which could be cleaved by furin and/or furin-like PCs secreted from host cells and bacteria in the airway epithelium. Unlike the first SARS-CoV, cell entry of SARS-CoV-2 is pre-activated by furin and/or furin-like PCs, reducing its dependence on target cell proteases for entry. The cleavage activation of S-protein is well demonstrated to be essential for SARS-CoV-2 spike-mediated viral binding to ACE2, cell-to-cell fusion, and viral entry into human lung cells.

The first of the two kits by EpiGentek, CoviDrop SARS-CoV-2 Targeted Proprotein Convertase Inhibitor Screening Fast Kit, screens for inhibitors of SARS-CoV-2 targeted furin and PCs. It is an ELISA-like procedure which can be completed within two hours. By using a SARS-CoV-2 specific substrate which is proven to be the same as the complete trimeric form of full length SARS-CoV-2 spike protein in our tests with this kit, the SARS-coV-2 furin site was found to be cleaved not only by furin but also by other serine proteases such as plasmin and human airway trypsin (HAT).

The second kit, CoviDrop SARS-CoV-2 Targeted Proprotein Convertase Activity/Inhibition Assay Kit, quantitatively measures the activity or inhibition levels of furin or furin-like PC as well as facilitated proteases in biological samples such as nasal swabs. It is also similarly ELISA-based and needs only 50 minutes from start to finish. The CoviDrop kits are unique in the market and may be a key tool in better understanding of infection mechanisms and discovery of potent inhibitors against SARS-CoV-2. EpiGentek has also recently released a series of other assay kits to rapidly detect SARS-CoV-2 neutralizing antibodies and measure spike-ACE2 binding activity or inhibition.

"These highly demanded products enable academic and biotechnology to have a much-needed novel approach towards rapidly identifying prevention and therapy initiatives of SARS-CoV-2," said William Lee, EpiGentek's Chief Operating Officer.

Related Links:
EpiGentek

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
SARS-CoV-2 Test
One Step SARS-CoV-2 Nucleic Acid Detection Kit (P761H)

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.